GAMP 5 Validation Consultant for Risk-Based Pharmaceutical CSV
Founder-led GAMP 5 validation consulting from system classification and supplier assessment through URS, risk-based testing, traceability and defensible closure.
PHARPRO computerized system validation (CSV) consulting delivers the complete URS-through-VSR documentation lifecycle for pharmaceutical and life sciences companies in Jordan, UAE, Saudi Arabia, and across the MENA region. Fixed-price projects aligned with FDA 21 CFR Part 11, EU GMP Annex 11, and ISPE GAMP 5. Remote delivery available. Typical engagement: 6–12 weeks per system.
Start your CSV project
Tell us about your system - we'll respond within one business day with a clear scope and fixed-price proposal.
A complete, audit-ready CSV package
Every engagement produces structured, traceable documentation that holds up in an FDA, EU GMP, or WHO inspection.
User Requirements Specification (URS)
Structured URS aligned to regulatory expectations - covering functional, performance, and compliance requirements with full traceability.
Risk Classification & Assessment
GAMP 5 category assignment, GxP impact analysis, and risk-based validation strategy - proportionate to system complexity.
Validation Master Plan (VMP)
Site-level or project-level VMP establishing scope, responsibilities, documentation standards, and acceptance criteria framework.
IQ / OQ / PQ Protocols & Reports
Installation, Operational, and Performance Qualification - written, executed, and reported to regulatory standards with full discrepancy management.
Audit Trail & Data Integrity Review
21 CFR Part 11 and EU GMP Annex 11 audit trail verification - covering access controls, timestamps, change records, and ALCOA+ compliance.
Validation Summary Report (VSR)
Comprehensive closure report consolidating all validation activities, outcomes, and residual risks - ready for regulatory filing.
Every document is built to survive an inspection
We write to the current version of each framework, cross-referencing where requirements overlap or diverge.
| Framework | Scope | Applies To |
|---|---|---|
| FDA 21 CFR Part 11 | Electronic records, e-signatures, audit trails | US FDA-regulated markets |
| EU GMP Annex 11 | Computerised systems in GMP-regulated operations | EMA / EU-regulated markets |
| ISPE GAMP 5 | Risk-based approach to CSV - categories 1–5 | All regulated pharma environments |
| ICH Q10 | Pharmaceutical Quality System lifecycle management | Global regulated markets |
Every computerised system in your GxP environment
From enterprise software to lab instruments - if it touches a regulated process, we validate it.
Common CSV questions
CSV experience with transparent scope
Review the dated CSV, ERP, BMS, software-gap and training engagements. Client logos, quotations and outcome metrics remain withheld until reuse permission is confirmed.
View project record →Go deeper on CSV methodology
In-depth guides from Mohammad Awawdeh on IQ/OQ/PQ, GAMP 5, URS writing, and validation documentation best practice.
Complete compliance support
Related Reading
Why PHARPRO
Practical CSV validation support with audit-defensible outputs
PHARPRO aligns each engagement with the regulations and guidance applicable to the client’s product, market and quality system. Final responsibility and approval remain with the regulated company.
Need a focused FDA Part 11 assessment?
Review electronic records, audit trails, e-signatures, access controls and remediation requirements with PHARPRO's dedicated 21 CFR Part 11 consulting service for the Middle East.